and Guillain-Barre syndrome (GBS). Generally, CIDP symptoms emerge slowly over at least 2 months and feature weakness developing symmetrically on both sides of the body. Lack of deep reflexes and ...

The 2021 EAN/PNS guideline task force was supported by the European Academy of Neurology, the Peripheral Nerve Society, the ...

Early diagnosis is often the key to successful treatment in any medical condition, but some diseases are particularly tricky ...

CIDP treatment focuses on reducing and slowing the immune processes damaging your peripheral nervous system. It includes corticosteroids, intravenous immunoglobulin, and plasma exchange, but new ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...